Latest Listing Rules News

The Agency Group Australia (ASX:AU1) acknowledged ongoing discussions with Aura Group following a spike in share trading and an ASX inquiry. No binding deal is in place, and the company will update the market on material developments.

Wellnex Life has agreed to sell its Pain Away brand to Mentholatum Australasia for up to A$21.3 million, aiming to wipe out debt and sharpen its strategic focus.

Synertec Corporation has affirmed that its recent announcements on a $4 million AGL contract and a 40-50% revenue growth forecast for FY27 were material and disclosed promptly, maintaining confidentiality until release.

NH3 Clean Energy has raised $4 million through a private placement priced at an 18.4% discount to fund front-end engineering and design work for its WAH2 clean ammonia project, signalling strong institutional backing as it approaches key development milestones.

Sky Metals has voluntarily suspended its ASX-listed securities pending a material announcement regarding its Tallebung Tin-Tungsten-Silver Project, with trading expected to resume by 10 August or upon release of the news.

Spacetalk Ltd has locked in $10 million through a two-tranche share placement, aiming to fund platform enhancements, inventory growth, and a major network migration.

Li-FT Power Ltd. has secured a C$20 million bought deal public offering priced at C$2.90 per share, aimed at funding care and maintenance for the Renard option period and general working capital. The deal includes a 15% over-allotment option and anticipates participation from cornerstone investor Avenir Minerals.

AuKing Mining has secured a full underwriting agreement with GBA Capital to guarantee raising approximately $9.14 million through the exercise of nearly 305 million unlisted options expiring in April 2027.

GWR Group plans a $19.85 million capital return equating to 6.1 cents per share, pending shareholder approval. The ASX has granted a waiver allowing the share price to fall below 20 cents post-distribution, enabling the return to proceed.

Fitzroy River Corporation has appointed Argonaut Corporate Finance as exclusive adviser to test market interest in selling its Bowdens Silver Project royalty, with no sale decision yet made.

Neurotech International has secured $4.5 million through a share placement to fund its pivotal Phase III clinical trial of NTI164 for Autism Spectrum Disorder, aiming to reach topline data readout.

Environmental Clean Technologies (ASX: ECT) disclosed confidential talks on acquiring Xenica Materials and a new engineering deal with Metallium amid a price surge, followed by a $12 million placement announcement.